
1303.1 - Lack of imaging response after initial TACE for HCC does not predict failure of subsequent TACE (ID: 16058)
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | not available |
| IROS 2012 | not available |
| ECIO 2012 | not available |
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | not available |
| IROS 2012 | not available |
| ECIO 2012 | not available |
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | not available |
| IROS 2012 | not available |
| ECIO 2012 | not available |
P-266 - MR ONCO-TREAT: a new tool for the assessment of hepatic tumors treated with trans-arterial therapy and monitored with multi-modal MRI (ID: 44139)
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | not available |
| IROS 2012 | not available |
| ECIO 2012 | not available |
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | not available |
| IROS 2012 | not available |
| ECIO 2012 | not available |
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | not available |
| IROS 2012 | not available |
| ECIO 2012 | not available |
P-324 - Phase II trial of bevacizumab combined with transarterial chemoembolization (TACE) for hepatocellular carcinoma: initial experience at two institutions (ID: 44197)
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | not available |
| IROS 2012 | not available |
| ECIO 2012 | not available |
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | not available |
| IROS 2012 | not available |
| ECIO 2012 | not available |
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | not available |
| IROS 2012 | not available |
| ECIO 2012 | not available |
2109.1 - Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug eluting beads for hepatocellular carcinoma (ID: 57498)
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | free |
| IROS 2012 | not available |
| ECIO 2012 | not available |
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | free |
| IROS 2012 | not available |
| ECIO 2012 | not available |
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | not available |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | free |
| IROS 2012 | not available |
| ECIO 2012 | not available |
1909.3 - Prospective phase II trial of sorafenib combined with doxorubicin eluting bead-transarterial chemoembolization for patients with unresectable hepatocellular carcinoma: an interim analysis (ID: 46503)
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | free |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | not available |
| IROS 2012 | not available |
| ECIO 2012 | not available |
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | free |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | not available |
| IROS 2012 | not available |
| ECIO 2012 | not available |
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | free |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | not available |
| IROS 2012 | not available |
| ECIO 2012 | not available |
1202.2 - Prospective, phase II study of chemoembolization with drug-eluting beads for hepatic neuroendocrine metastases: interim analysis (ID: 45541)
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | free |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | not available |
| IROS 2012 | not available |
| ECIO 2012 | not available |
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | free |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | not available |
| IROS 2012 | not available |
| ECIO 2012 | not available |
| Non-Attendee | not available |
|---|---|
| MEMBER | free |
| CIRSE 10 | free |
| eSir Zagreb | not available |
| eSir Amsterdam | not available |
| IROS 2011 | not available |
| eSir Amsterdam 2011 | not available |
| eSir Frankfurt 2011 | not available |
| GEST 2011 | not available |
| eSir Ingolstadt 2011 | not available |
| buy_test | free |
| cme_test | free |
| CIRSE 11 | not available |
| IROS 2012 | not available |
| ECIO 2012 | not available |